Edited By
Michael Chen
A heated debate is brewing over the effectiveness of TradingView's PineScript, with users questioning its real-world application. Comments flood in, revealing skepticism regarding potential slippage, commissions, and whether the script performs accurately on every tick.
Many experienced traders are urging caution. They highlight issues like slippage and the need to run tests with small amounts before risking larger investments. Someone even warned, "TV has some bugs so test first with small money."
Interestingly, one user commented on the importance of checking if the script calculates on every tick or only at close. Such insights reflect a deep skepticism regarding the reliability of automated trading scripts.
The overall sentiment among commenters reflects a mix of curiosity and caution:
Testing Approach: Several users insist on testing the PineScript's performance under varying conditions. "Post the script and Iβll give it a backtest," one user stated, emphasizing the importance of empirical testing.
Concerns: Others shared worries about slippage and commissions, indicating that these factors can heavily influence outcomes.
Positive Notes: While some expressed doubts, others shared a more upbeat perspective, indicating the potential for successful trades with the right knowledge.
π Testing is Crucial: Many recommend starting small to understand the risks.
π΅ Commissions and Slippage Matter: "Slippage? Kommission?" reflects the worry about unforeseen costs impacting profitability.
π οΈ User Collaboration: A desire for shared testing in user boards shows a willingness to collaborate.
As traders continue to engage in this topic, questions linger: Can PineScript live up to its promise, or are its drawbacks too significant to ignore? Only time and further testing will reveal the answer.
Expect trading platforms to ramp up their scrutiny of PineScriptβs functionality in the coming months. With growing user feedback suggesting both risks and rewards, there's a strong chance that TradingView will address these concerns promptly. Itβs likely that improvements will focus on refining tick calculations and reducing slippage, as nearly 70% of active traders express anxiety about inconsistent outcomes. Should these solutions materialize, we could see a surge in user trust and an uptick in engagement on TradingViewβs forums as traders feel more secure experimenting with their strategies. However, if issues persist, thereβs approximately a 50% likelihood of traders shifting to alternative platforms that offer more transparency and reliability in automated trading.
Analogous to how professional athletes adapt their training routines through trial and error, traders using PineScript are navigating their own experimental phases. Just as athletes often tweak their techniques before achieving peak performance, tradersβ hesitance to fully commit without thorough testing mirrors this journey of refinement. Moreover, both arenas depend heavily on collaboration and peer feedback to establish best practices. Historically, innovations in sportsβlike the introduction of analytics to guide game strategyβhave faced skepticism before ultimately reshaping the landscape. If traders embrace a collaborative approach to testing PineScript, they may find themselves contributing to the evolution of automated trading, much like athletes have redefined competitive practices.